Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $29 | $23 | $18 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $19 | $11 | $3 | $4 |
| Inventory | $8 | $13 | $13 | $10 |
| Other Curr. Assets | $4 | $2 | $1 | $1 |
| Total Curr. Assets | $48 | $55 | $40 | $32 |
| Property Plant & Equip (Net) | $14 | $15 | $15 | $13 |
| Goodwill | $0 | $3 | $6 | $6 |
| Intangibles | $0 | $0 | $4 | $4 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $14 | $18 | $25 | $24 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $63 | $73 | $65 | $56 |
| Liabilities | – | – | – | – |
| Payables | $3 | $8 | $6 | $3 |
| Short-Term Debt | $20 | $2 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $2 | $0 |
| Other Curr. Liab. | $16 | $5 | $4 | $2 |
| Total Curr. Liab. | $39 | $15 | $12 | $6 |
| LT Debt | $6 | $24 | $25 | $25 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $24 | $25 | $25 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $45 | $39 | $37 | $32 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$154 | -$131 | -$97 | -$72 |
| AOCI | -$0 | -$1 | -$0 | $0 |
| Other Equity | $172 | $166 | $125 | $95 |
| Total Equity | $18 | $34 | $28 | $24 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $63 | $73 | $65 | $56 |
| Net Debt | $7 | -$3 | $2 | $7 |